NOTCH2NLC: A Potential Drug Target and Biomarker (G100996717)

Target Name: NOTCH2NLC

NCBI ID: G100996717

NOTCH2NLC

NOTCH2NLC: A Potential Drug Target and Biomarker

Notch signaling pathway is a crucial factor in cell proliferation, survival, and development. The NOTCH2 gene is a key regulator of the NOTCH signaling pathway. It encodes a transmembrane protein, NOTCH2NLC, which plays a crucial role in the regulation of stem cell properties and the development of tissues. The NOTCH2NLC protein is a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

The NOTCH signaling pathway has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. The NOTCH2 gene encodes a transmembrane protein that is involved in the regulation of stem cell properties and the development of tissues. The NOTCH2NLC protein is a key regulator of the NOTCH signaling pathway. It plays a crucial role in the regulation of stem cell proliferation, differentiation, and survival.

The NOTCH2NLC protein is a glycoprotein that contains a Notch2B subunit and a Notch1 subunit. The Notch2B subunit is a 240-kDa protein that is involved in the regulation of stem cell proliferation and differentiation. The Notch1 subunit is a 160-kDa protein that is involved in the regulation of stem cell survival and self-renewal.

The NOTCH2NLC protein is expressed in a variety of tissues, including stem cells, neurons, and glial cells. It is involved in the regulation of stem cell properties, including cell proliferation, differentiation, and survival. The NOTCH2NLC protein is also involved in the regulation of tissue homeostasis, including the regulation of cell migration and the maintenance of tissue structure.

The NOTCH2NLC protein has been implicated in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that NOTCH2NLC is involved in the regulation of cancer cell growth and survival. It has also been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its involvement in disease, the NOTCH2NLC protein is also a potential drug target. The NOTCH2NLC protein has been shown to be involved in the regulation of stem cell properties and the development of tissues, making it a potential target for drugs that can modulate these properties. Studies have shown that inhibiting NOTCH2NLC can lead to the regression of cancer cells and improve the survival of neurodegenerative diseases.

The NOTCH2NLC protein is also a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. The NOTCH2NLC protein is involved in the regulation of stem cell properties and the development of tissues, making it a potential target for biomarkers that can be used to diagnose and monitor these diseases.

In conclusion, NOTCH2NLC is a protein that is involved in the NOTCH signaling pathway and plays a crucial role in the regulation of stem cell properties and the development of tissues. Its involvement in the regulation of cancer, neurodegenerative diseases, and autoimmune diseases makes it a potential drug target and biomarker. Further research is needed to fully understand the role of NOTCH2NLC in disease and to develop effective treatments.

Protein Name: Notch 2 N-terminal Like C

The "NOTCH2NLC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NOTCH2NLC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets